NIPRO-JMI Joint Venture celebrates 12th anniversary

JMI Group, Bangladesh's leading conglomerate in pharmaceuticals and medical device sector, has completed its 12-year journey with NIPRO Corporation, a Japan-based leading global healthcare company.
To celebrate the 12th anniversary, an event titled, 'NIPRO-JMI Joint Venture: The trend setter of Japanese equity investment in Bangladesh's healthcare sector' was held at a city hotel on Tuesday, says a press release.
It was disclosed at the event that the five entities under NIPRO-JMI Joint Venture have received 80 million dollars (Tk 680 crore) foreign direct investment (FDI) from Japan during this 12-year journey.
The NIPRO-JMI Joint Venture started its business through manufacturing medical devices in 2011 and later expanded to healthcare services, pharmaceuticals and product marketing sectors. Around 5,500 employees currently work at five business entities under the joint venture initiative.
It was also said that the manufacturing units under the NIPRO-JMI Joint Venture produce more than 100 types of healthcare products, including 25 that have been made in Bangladesh for the first time. The entities under the Joint Venture regularly export their products to more than 40 countries, including many in Asia, Europe, Middle East, South America and Africa.
Home Minister Asaduzzaman Khan was present at the event as the chief guest while Planning Minister M A Mannan as special guest.
JMI Group Founder and Managing Director Md Abdur Razzaq, JMI Group Chairman Md Jabed Iqbal Pathan, Japanese Ambassador to Bangladesh ITO Naoki, Managing Director of NIPRO Corporation (Global Business Division) Tsuyoshi Yamazaki, Swadhinata Chikitshak Parishad President Dr M Iqbal Arslan and Executive Director of NIPRO-JMI Medical Kunio (Kenny) Takamido were also present.